HR 2040, the NEWBORN Act, creates federal grants for local health departments to run infant mortality pilot programs in the 50 highest-risk counties. The $10 million annual funding (2025-2029) requires grantees to develop community-specific plans addressing causes like preterm birth, maternal complications, and infant injuries. Programs must include outreach to at-risk mothers, standardized services (postpartum care, smoking cessation, nutrition counseling), rural health initiatives, and public education campaigns. Grantees must report annually on program outcomes, with funds limited to 10% for evaluation. The bill directly affects communities with high infant mortality rates and at-risk mothers and infants through these targeted, evidence-based interventions.
S 2377, the EACH Act of 2025, requires all federal health programs - including Medicaid, Medicare, the Children’s Health Insurance Program (CHIP), and the Indian Health Service - to cover abortion services without restrictions based on income or insurance type. It repeals the Hyde Amendment (Section 1303 of the ACA), which previously barred federal funds from covering most abortions, and prohibits state or private insurance plans from restricting abortion coverage. This directly affects millions enrolled in federal health programs, particularly low-income individuals, women of color, and young people, who face barriers to abortion access under current laws. The bill mandates that all federally funded health programs provide comprehensive abortion coverage as a standard benefit.
This bill expands Medicare, Medicaid, and CHIP coverage for specific cancer diagnostic tests, directly affecting cancer patients enrolled in these programs. It requires Medicare to cover genetic tests like DNA sequencing (80% of cost) and limits testing frequency to once at diagnosis, once for recurrence, and as needed for treatment planning. Medicaid and CHIP must include these tests as mandatory coverage starting January 1, 2027, with states given flexibility to comply via state legislation. The bill also mandates a new HHS education program to inform doctors and the public about genomic testing for cancer care.
Care for Military Kids Act This bill requires a state Medicaid program to consider active-duty members of the Armed Forces and their dependents who are receiving home- and community-based services to be residents of that state even if they are relocated to another state because of their military service, unless the member chooses not to be considered as such. The requirement applies beginning in 2028. The bill provides funds through FY2030 for the Centers for Medicare & Medicaid Services to implement the bill.
The Cure Hepatitis C Act of 2025 establishes a national program to eliminate hepatitis C virus in the United States by providing free treatment to people with hepatitis C who are in correctional facilities, enrolled in Medicaid or CHIP programs, receiving care through Indian Health Services, or without health insurance. The bill creates a subscription program where the Secretary of Health and Human Services will purchase and distribute hepatitis C treatments directly to covered populations without cost-sharing, while also establishing a national strategy, implementation plan, and public dashboard to monitor progress. It includes $5.5 billion for treatment access and $4.283 billion for public health activities like screening, diagnosis, and community outreach to improve hepatitis C treatment outcomes. The program requires participation from the Bureau of Prisons and Indian Health Service, and aims to coordinate care across health systems to eliminate hepatitis C virus.
This bill amends federal Medicaid rules to extend health coverage for former foster youth until age 26. It directly affects individuals who were in state foster care at age 18 (or left care via guardianship/emancipation before 18) and are under 26. The key provision removes the previous age cutoff by updating eligibility criteria in the Social Security Act, allowing these young adults to remain enrolled in Medicaid if they meet income requirements. The changes take effect January 1, 2026, for those turning 18 on or after that date, and require states to implement outreach programs by that date to help eligible individuals enroll.
The ENROLL Act of 2025 modifies the Affordable Care Act's navigator program, which helps people enroll in health insurance. It requires states and federal exchanges to award grants based on an entity’s capacity to provide services, not whether they cover non-qualified health plans, and ensures at least one annual grant goes to community-focused nonprofits. The bill expands navigators’ duties to include explaining Medicaid and children’s health insurance programs (CHIP) in clear language, mandates in-person assistance options, and allocates $100 million annually from insurer user fees for federal exchanges starting in 2026. These changes directly affect navigators, health insurance exchanges, and consumers seeking coverage under the Affordable Care Act.
The ADAPT Act (S 2356) expands Medicare coverage to include services provided by advanced psychology trainees - such as doctoral interns and postdoctoral residents in APA-accredited programs - under the general supervision of a licensed clinical psychologist (without requiring the supervisor's physical presence during services). It mandates the creation of a new billing code (GC modifier) for these services and directs the Department of Health and Human Services to issue guidance to states on covering these services under Medicaid and CHIP. This bill directly affects trainees, Medicare beneficiaries, and state Medicaid programs by streamlining access to mental health care through standardized billing and coverage mechanisms.
S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
This bill removes an age limit that previously restricted continuous Medicaid and CHIP coverage to children under 19. It changes the rules to apply 12-month continuous enrollment protections to all enrollees, regardless of age, by replacing "child" and age-specific language with "individual" throughout the program rules. The key mechanism is amending federal law to eliminate the requirement that beneficiaries must be under 19 to qualify for uninterrupted coverage. This directly affects all current and future Medicaid and CHIP participants, including adults and older children. The changes take effect in 2026.
